EMEA-002018-PIP02-16-M01

Key facts

Invented name
Venclyxto
Active substance
Venetoclax
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0001/2019
PIP number
EMEA-002018-PIP02-16-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Tablet for oral suspension
Condition(s) / indication(s)
  • Treatment of malignant neoplasms of the haematopoietic and lymphoid tissue
  • Treatment of solid malignant tumours
Route(s) of administration
Oral use
Contact for public enquiries
AbbVie Ltd

E-mail: paediatricteam@abbvie.com
Tel. +44 (0)1628 408248

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating